Tongue, Oral Cavity, Pharynx, Nasopharynx Tumors

Neutron therapy is appropriate for the following histologies:

  • Acinic Cell Carcinoma
  • Adenocarcinoma
  • Adenoid cystic carcinoma
  • Melanoma
  • Mucoepidermoid carcinoma
  • Soft-tissue sarcoma
  • Squamous Cell Carcinoma
Patients who may benefit from neutron therapy include:
  • Newly diagnosed patients with unresectable (inoperable) disease, or residual disease following surgery (positive margins).
  • Patients whose disease has recurred after surgery and/or radiation.
  • Patients who have no residual disease following surgery but are considered at risk for recurrence.

For general questions please contact   For web questions, email   Or call 630-840-3865
Security, Privacy, LegalFermi National Accelerator Laboratory

Security, Privacy, Legal